Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit ...United Arab Emirates

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.

Read More Details
Finally We wish PressBee provided you with enough information of ( Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit )

Also on site :

• Why Russia and China are Vying For Influence in Afghanistan
• ENERGIZER HOLDINGS, INC. Completes Acquisition of Advanced Power Solutions NV
• INTERTEK LAUNCHES SUPPLYTEK, THE WORLD'S FIRST END-TO-END GLOBAL MARKET ACCESS SOLUTION TURNING SUPPLY CHAIN UNCERTAINTY INTO A COMPETITIVE ADVANTAGE FOR ITS CLIENTS